Abbott Announces Recall of Infant Formula Over Defective Caps
MONDAY, Oct. 17, 2022 (HealthDay News) — Abbott Inc. has announced that it is again recalling some of its infant formula products, though the company said this latest recall is small and should not significantly impact nationwide supply.This recall w…
Learn MoreToo Few Young People Get Mental Health Follow-Up After ER Visit
MONDAY, Oct. 17, 2022 (HealthDay News) — When teens and young adults go to the emergency room or are hospitalized for critical mental health issues a staggering number are not receiving quick follow-up care, new U.S. research finds.Researchers at th…
Learn MoreWhat’s Keeping Some Hispanic Americans From Getting the COVID Shot?
MONDAY, Oct. 17, 2022 (HealthDay News) – While a large number of Hispanic Americans have received at least one dose of a COVID-19 vaccine at this point, a new study suggests barriers may still stand in the way for those who might want to get shots.Res…
Learn MoreNew Omicron Variants Gaining Foothold in U.S.
MONDAY, Oct. 17, 2022 (HealthDay News) – New, more contagious Omicron variants are starting to spread across the United States, new government data show.Luckily, they’re related to the Omicron variant BA.5, so recently updated booster shots should pro…
Learn MoreTelehealth Boosts Odds That Patients Show Up for Post-Surgery Care
MONDAY, Oct. 17, 2022 (HealthDay News) — Telehealth became a common way for doctors to see patients during the early days of the pandemic.New research suggests that surgical patients offered virtual care are far more likely to keep appointments befor…
Learn MoreEven Without Symptoms, COVID Infection Raises Risks for Trauma Patients
MONDAY, Oct. 17, 2022 (HealthDay News) — Having COVID-19 could cause further trouble for patients being treated for physical trauma — even if they have no symptoms of the virus. Researchers studying cases of trauma patients who tested positive for CO…
Learn MoreMost Docs Want Telehealth for Opioid Abuse Treatment to Stick Around
MONDAY, Oct. 17, 2022 (HealthDay News) — Many doctors who used telehealth to treat patients with opioid addiction because of the COVID-19 pandemic would like to make it a permanent part of their practice. A new study from Yale School of Public Health…
Learn MoreUna terapia genética ayuda a las personas con una forma rara de ceguera a ver mejor de noche
JUEVES, 13 de octubre de 2022 (HealthDay News) — Una terapia genética experimental ofrece esperanzas de una rápida mejora de la visión nocturna a los adultos que sufren de una forma congénita de ceguera de inicio en la niñez, informan unos investigad…
Learn MoreEstar a la altura: unos científicos encuentran un gen relacionado con la estatura
JUEVES, 13 de octubre de 2022 (HealthDay News) — La respuesta a qué tan alto será un niño en general se estima basándose en un promedio de las estaturas de sus padres.Pero un estudio australiano que incluyó a más de 5 millones de personas encontró qu…
Learn MoreLa FDA advierte que Adderall, un fármaco para el TDAH, escasea
JUEVES, 13 de octubre de 2022 (HealthDay News) — Las personas con un trastorno de déficit de atención e hiperactividad (TDAH) o narcolepsia quizá dependan del medicamento Adderall, pero el fármaco está escaseando, anunció el miércoles la Administraci…
Learn More